• LAST PRICE
    590.1450
  • TODAY'S CHANGE (%)
    Trending Up12.2150 (2.1136%)
  • Bid / Lots
    589.7500/ 1
  • Ask / Lots
    590.4800/ 4
  • Open / Previous Close
    580.1700 / 577.9300
  • Day Range
    Low 578.8100
    High 593.4200
  • 52 Week Range
    Low 415.6000
    High 603.8200
  • Volume
    200,118
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 577.93
TimeVolumeTMO
09:32 ET25215579.81
09:34 ET2381578.96
09:38 ET954583.18
09:39 ET2609585.11
09:41 ET10640587.26
09:43 ET7979588.99
09:45 ET4854588.46
09:48 ET3126591.055
09:50 ET3585591.01
09:52 ET4681591.81
09:54 ET800591.62
09:56 ET5990591.93
09:57 ET552592.345
09:59 ET12551592.119
10:01 ET1000592.34
10:03 ET3691590.99
10:06 ET4668590.29
10:08 ET2222590.135
10:10 ET5153590.1917
10:12 ET3600589.095
10:14 ET1562588.97
10:15 ET2871589.76
10:17 ET1322589.79
10:19 ET3076590.205
10:21 ET1200590.145
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTMO
Thermo Fisher Scientific Inc
220.6B
37.9x
+15.48%
United StatesDHR
Danaher Corp
186.2B
46.4x
+10.83%
United StatesBSX
Boston Scientific Corp
108.9B
62.0x
-1.29%
United StatesISRG
Intuitive Surgical Inc
136.7B
70.0x
+9.70%
United StatesGEHC
GE Healthcare Technologies Inc
37.8B
24.1x
---
United StatesPHG
Koninklijke Philips NV
24.1B
-28.8x
---
As of 2024-05-10

Company Information

Thermo Fisher Scientific Inc. is engaged in helping life sciences research, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. The Company's Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.

Contact Information

Headquarters
168 Third AvenueWALTHAM, MA, United States 02451
Phone
781-622-1000
Fax
781-622-1207

Executives

Chairman of the Board, President, Chief Executive Officer
Marc Casper
Chief Financial Officer, Senior Vice President
Stephen Williamson
Chief Operating Officer, Executive Vice President
Michel Lagarde
Executive Vice President
Gianluca Pettiti
Senior Vice President, General Counsel
Michael Boxer

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$220.6B
Revenue (TTM)
$42.5B
Shares Outstanding
381.7M
Dividend Yield
0.26%
Annual Dividend Rate
1.5600 USD
Ex-Dividend Date
03-14-24
Pay Date
04-15-24
Beta
0.80
EPS
$15.59
Book Value
$120.87
P/E Ratio
37.9x
Price/Sales (TTM)
5.2
Price/Cash Flow (TTM)
23.5x
Operating Margin
16.38%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.